LIVN LivaNova PLC

  1. Stocks
  2. Healthcare
  3. NASDAQ: LIVN

Price (delayed)

$54.74

Market cap

$2.95B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.82

Enterprise value

$3.03B

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through ...

Highlights
LivaNova's quick ratio has increased by 13% QoQ and by 13% YoY
LivaNova's revenue has increased by 7% YoY and by 3.8% from the previous quarter
LIVN's debt is up by 23% year-on-year and by 8% since the previous quarter
The net income is down by 19% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.livanova.com
Peers: PDEX OFIX NVRO

Key stats

What are the main financial stats of LIVN
Market
Shares outstanding
53.88M
Market cap
$2.95B
Enterprise value
$3.03B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.37
Price to sales (P/S)
2.72
EV/EBIT
N/A
EV/EBITDA
106.99
EV/Sales
2.79
Earnings
Revenue
$1.08B
EBIT
-$30.42M
EBITDA
$28.32M
Free cash flow
$28.64M
Per share
EPS
-$1.82
Free cash flow per share
$0.53
Book value per share
$23.07
Revenue per share
$20.16
TBVPS
$22.4
Balance sheet
Total assets
$2.34B
Total liabilities
$1.1B
Debt
$614.25M
Equity
$1.24B
Working capital
$653.67M
Liquidity
Debt to equity
0.5
Current ratio
3.27
Quick ratio
2.5
Net debt/EBITDA
2.82
Margins
EBITDA margin
2.6%
Gross margin
67.6%
Net margin
-9%
Operating margin
-9.5%
Efficiency
Return on assets
-4.3%
Return on equity
-8.1%
Return on invested capital
-3.3%
Return on capital employed
-1.5%
Return on sales
-2.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LIVN stock price

How has the LivaNova stock price performed over time
Intraday
-1.88%
1 week
-5.29%
1 month
-1.01%
1 year
10.92%
YTD
-1.44%
QTD
6.44%

Financial performance

How have LivaNova's revenue and profit performed over time
Revenue
$1.08B
Gross profit
$733.72M
Operating income
-$102.98M
Net income
-$97.16M
Gross margin
67.6%
Net margin
-9%
The net income is down by 19% from the previous quarter
The company's operating income fell by 16% QoQ
LIVN's net margin is down by 15% since the previous quarter
LivaNova's operating margin has decreased by 12% QoQ

Growth

What is LivaNova's growth rate over time

Valuation

What is LivaNova stock price valuation
P/E
N/A
P/B
2.37
P/S
2.72
EV/EBIT
N/A
EV/EBITDA
106.99
EV/Sales
2.79
LivaNova's EPS has decreased by 19% QoQ
The price to book (P/B) is 12% lower than the 5-year quarterly average of 2.7 but 8% higher than the last 4 quarters average of 2.2
The equity has declined by 3.2% year-on-year
The price to sales (P/S) is 20% lower than the 5-year quarterly average of 3.4 but 4.6% higher than the last 4 quarters average of 2.6
LivaNova's revenue has increased by 7% YoY and by 3.8% from the previous quarter

Efficiency

How efficient is LivaNova business performance
The ROIC has plunged by 194% YoY and by 74% from the previous quarter
LivaNova's return on sales has shrunk by 75% QoQ
The return on equity has declined by 21% since the previous quarter
The company's return on assets fell by 19% QoQ

Dividends

What is LIVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LIVN.

Financial health

How did LivaNova financials performed over time
The company's total assets is 113% higher than its total liabilities
The current ratio has grown by 14% since the previous quarter and by 12% year-on-year
LivaNova's quick ratio has increased by 13% QoQ and by 13% YoY
LIVN's debt is 50% smaller than its equity
LIVN's debt to equity is up by 28% year-on-year and by 6% since the previous quarter
LIVN's debt is up by 23% year-on-year and by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.